Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesChange in Working CapitalExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVSEF) Change in Intangibles (2016 - 2025)

Historic Change in Intangibles for Novartis Ag (NVSEF) over the last 16 years, with Q4 2025 value amounting to -$408.0 million.

  • Novartis Ag's Change in Intangibles rose 2879.58% to -$408.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.4 billion, marking a year-over-year increase of 392.16%. This contributed to the annual value of -$2.4 billion for FY2025, which is 392.16% up from last year.
  • Per Novartis Ag's latest filing, its Change in Intangibles stood at -$408.0 million for Q4 2025, which was up 2879.58% from -$477.0 million recorded in Q3 2025.
  • Novartis Ag's Change in Intangibles' 5-year high stood at -$188.0 million during Q3 2021, with a 5-year trough of -$1.2 billion in Q1 2025.
  • Moreover, its 5-year median value for Change in Intangibles was -$445.0 million (2023), whereas its average is -$472.8 million.
  • As far as peak fluctuations go, Novartis Ag's Change in Intangibles surged by 6328.9% in 2023, and later crashed by 32036.2% in 2024.
  • Quarter analysis of 5 years shows Novartis Ag's Change in Intangibles stood at -$517.0 million in 2021, then surged by 62.86% to -$192.0 million in 2022, then crashed by 96.35% to -$377.0 million in 2023, then plummeted by 51.99% to -$573.0 million in 2024, then increased by 28.8% to -$408.0 million in 2025.
  • Its Change in Intangibles stands at -$408.0 million for Q4 2025, versus -$477.0 million for Q3 2025 and -$227.0 million for Q2 2025.